Zacks Investment Research downgraded shares of CORP EXEC BRD (CEB) from OUTPERFORM to NEUTRAL on October 02, 2012, with a target price of $57.10.
Corporate Executive Board provides "best practices" research and analysis focusing on corporate strategy, operations and general management issues. Best practices research identifies and analyzes specific management initiatives, processes and strategies that have been determined to produce the best results in solving common business problems or challenges. The company provides research and analysis on an annual subscription basis to some of the world's largest and most prestigious corporations.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on CORP EXEC BRD (CEB),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment